DCLA
TEVA icon

Douglas C. Lane & Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Douglas C. Lane & Associates’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$211K Buy
+3,221
New +$199K 0.01% 212
2013
Q4 		– Sell
-9,855
Closed -$372K – 198
2013
Q3 		$372K Sell
9,855
-4,074
-29% -$159K 0.01% 164
2013
Q2 		$546K Buy
+13,929
New +$542K 0.02% 153

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Douglas C. Lane & Associates's TEVA Position: Q4 2015 in Review

Douglas C. Lane & Associates opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2015: 3,221 shares worth $211K. The stake represents 0.01% of the portfolio and ranks #212 among its holdings. This is a return to the name: Douglas C. Lane & Associates previously reported a position in TEVA as recently as Q3 2013.

Douglas C. Lane & Associates first reported a position in TEVA in Q2 2013 and has held it in 3 quarters since. The position peaked at $546K in Q2 2013. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

  • Douglas C. Lane & Associates held 3,221 shares of Teva Pharmaceuticals worth $211K as of Q4 2015.
  • Teva Pharmaceuticals was a new Douglas C. Lane & Associates position in Q4 2015.
  • Teva Pharmaceuticals made up 0.01% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #212 holding.
  • Douglas C. Lane & Associates first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • Douglas C. Lane & Associates's Teva Pharmaceuticals position peaked at $546K in Q2 2013.
  • 877 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.